Trump tariffs on the pharmaceutical sector. A new twist- the US department of commerce initiates a… Ashwin Sapra, Parter and Head, Pharmaceuticals, Life Sciences and Healthcare Practice, Cyril Amarchand Mangaldas Apr 22, 2025 Ashwin Sapra highlights how the US Section 232 investigation into pharma imports marks a significant escalation in Trump-era trade…
